spacer
home > pmps > winter 2017 > breathing space
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing Space

Inhalation technology is considered to be one of the most feasible administration options for patients as, unlike other methods of application, it is painless and flexible. This drug delivery technology is gaining increasing importance for the treatment of asthma, chronic obstructive pulmonary disease (COPD), respiratory allergies and cystic fibrosis, among others. Due to the large surface area presented by the respiratory tract, this route expedites drug absorption and onset action, while allowing for smaller doses to be administered. It has also been found to increase patient compliance.

However, there are various disadvantages associated with inhalation technology such as:
  • Persistent drug irritation
  • The risk of toxic particles affecting the lungs
  • Drug stability issues
  • Deposition of aerosolised particles in the oropharyngeal area and within the upper airway


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
With over 10 years of experience in market research and consulting, Rajiv Kalia is Associate Director of Healthcare at MarketsandMarkets. He endeavours to constantly track and analyse healthcare market developments and research areas for the team. Prior to joining MarketsandMarkets, he has worked with WNS Global Services and Smartanalyst India Private Limited in similar areas.

With over five years of experience in healthcare market research and consulting, Ruchika Kakarya is a Senior Research Analyst of Healthcare at MarketsandMarkets. She specialises in market size estimations and building forecast models. Prior to joining MarketsandMarkets, Ruchika worked with WNS Global Services and Global Data Research Center in similar areas.

Experienced in market research and report writing, Pooja Ganguly is a Research Associate of Healthcare at MarketsandMarkets. With her strong technical, analytical knowledge, she provides business and market analysis solutions with detailed attention on forecasting, competitive intelligence, pricing analysis, identifying revenue pockets, understanding usage patterns and trends and supplyand demand-side analysis.
spacer
Rajiv Kalia
spacer
spacer
spacer
Ruchika Kakarya
spacer
spacer
spacer
Pooja Ganguly
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology

PHILADELPHIA August 12, 2019: Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions. By becoming a Signant Partner, CROs will benefit from new commercial and operational advantages that only come with membership.
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement